Mohamed Ismail Abdul Aziz

4PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 17, 2021
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore.

Li-Jen Cheng, Lydia Loke, Elaine Hsuen Lim

|Feb 17, 2021
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer.

Li-Jen Cheng, Grace Wong, Wen-Yee Chay

|Oct 21, 2020
Cost-effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore.

Lydia Loke, Soo-Chin Lee, Fiona Pearce

|Oct 15, 2020
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore.

Ling Eng Tan, Wan Hui Gloria Tan, Mohamed Ismail Abdul Aziz

Pageof 1

Frequent Collaborators

2 joint publications

Mohamed Ismail Abdul Aziz

2 joint publications

Lydia Loke

2 joint publications

Li-Jen Cheng

1 joint publications

Ling Eng Tan